A better comprehension of “Management of Hyperglycemia in Type 2 Diabetes:A Patient-Centered Approach—Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)”

TLDR: The position statement emphasizes that all patients should accept diabetes education aimed at hyperglycemia control and sets up the target of control of hyper glycemia flexibly according to natural course of disease, pathological condition,accompanied diseases, age, and life expectancy of the patients.

Abstract: " Management of Hyperglycemia in Type 2Diabetes : A Patient-Centered Approach — Position Statement of the American Diabetes Association(ADA) and the European Association for the Study of Diabetes(EASD)" was published in Diabetes Care and Diabetology in April this year.It,first,emphasizes the control of hyperglycemia in the treatment of T2DM;second,sets up the target of control of hyperglycemia flexibly according to natural course of disease,pathological condition,accompanied diseases,age,and life expectancy of the patients;third,once again emphasizes metformin for first-line use;fourth,more specifically discusses the applications,therapeutic effects,and advantages and disadvantages of various insulin preparations,GLP-1,DPP-4inhibitors and GLP-1receptor agonists;fifth,states the individualization treatment;and sixth,underlines that all patients should accept diabetes education aimed at hyperglycemia control.